108 related articles for article (PubMed ID: 8031997)
1. Oncostatin M stimulates proliferation in B9 hybridoma cells: potential role of oncostatin M in plasmacytoma development.
Barton BE; Jackson JV; Lee F; Wagner J
Cytokine; 1994 Mar; 6(2):147-53. PubMed ID: 8031997
[TBL] [Abstract][Full Text] [Related]
2. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T
J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046
[TBL] [Abstract][Full Text] [Related]
4. Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production.
Terada S; Suzuki E; Ueda H; Makishima F
Cytokine; 1996 Dec; 8(12):889-94. PubMed ID: 9050746
[TBL] [Abstract][Full Text] [Related]
5. Multiple cytokines inhibit interleukin-6-dependent murine hybridoma/plasmacytoma proliferation.
Schwabe M; Cox GW; Bosco MC; Prohaska R; Kung HF
Cell Immunol; 1996 Feb; 168(1):117-21. PubMed ID: 8599834
[TBL] [Abstract][Full Text] [Related]
6. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice.
Gyotoku E; Morita E; Kameyoshi Y; Hiragun T; Yamamoto S; Hide M
Arch Dermatol Res; 2001 Nov; 293(10):508-14. PubMed ID: 11820727
[TBL] [Abstract][Full Text] [Related]
7. Gp130 in human myeloma/plasmacytoma.
Tani Y; Nishimoto N; Ogata A; Shima Y; Yoshizaki K; Kishimoto T
Curr Top Microbiol Immunol; 1995; 194():229-33. PubMed ID: 7895494
[No Abstract] [Full Text] [Related]
8. Oncostatin M is a differentiation factor for myeloid leukemia cells.
Bruce AG; Hoggatt IH; Rose TM
J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
[TBL] [Abstract][Full Text] [Related]
9. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
10. Cloning and biological activity of murine oncostatin M.
Hara T; Ichihara M; Yoshimura A; Miyajima A
Leukemia; 1997 Apr; 11 Suppl 3():449-50. PubMed ID: 9209421
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.
Richards CD; Langdon C; Deschamps P; Pennica D; Shaughnessy SG
Cytokine; 2000 Jun; 12(6):613-21. PubMed ID: 10843736
[TBL] [Abstract][Full Text] [Related]
12. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G
FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M, but not interleukin-6 or leukemia inhibitory factor, stimulates expression of alpha1-proteinase inhibitor in A549 human alveolar epithelial cells.
Sallenave JM; Tremblay GM; Gauldie J; Richards CD
J Interferon Cytokine Res; 1997 Jun; 17(6):337-46. PubMed ID: 9198001
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M, leukaemia-inhibitory factor and interleukin 6 trigger different effects on alpha1-proteinase inhibitor synthesis in human lung-derived epithelial cells.
Cichy J; Rose-John S; Travis J
Biochem J; 1998 Jan; 329 ( Pt 2)(Pt 2):335-9. PubMed ID: 9425117
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling.
Liu J; Modrell B; Aruffo A; Marken JS; Taga T; Yasukawa K; Murakami M; Kishimoto T; Shoyab M
J Biol Chem; 1992 Aug; 267(24):16763-6. PubMed ID: 1324910
[TBL] [Abstract][Full Text] [Related]
17. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130.
Taga T; Narazaki M; Yasukawa K; Saito T; Miki D; Hamaguchi M; Davis S; Shoyab M; Yancopoulos GD; Kishimoto T
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10998-1001. PubMed ID: 1438305
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to rat soluble IL-6 receptor stimulate B9 hybridoma cell proliferation.
Thibault V; Richards CD; Botelho F; Gauldie J
FEBS Lett; 1997 May; 408(2):182-6. PubMed ID: 9187363
[TBL] [Abstract][Full Text] [Related]
19. Human interleukin for DA cells/leukemia inhibitory factor and oncostatin M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form.
Heymann D; Godard A; Raher S; Ringeard S; Lassort D; Blanchard F; Harb J
Cytokine; 1995 Feb; 7(2):111-7. PubMed ID: 7780030
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
